Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

OBJECTIVE—We explored whether cardiovascular disease (CVD) risk and the effects of fenofibrate differed in subjects with and without metabolic syndrome and according to various features of metabolic syndrome defined by the Adult Treatment Panel III (ATP III) in subjects with type 2 diabetes in the F...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Scott, Russell, O'Brien, Richard, Fulcher, Greg, Pardy, Chris, d'Emden, Michael, Tse, Dana, Taskinen, Marja-Riitta, Ehnholm, Christian, Keech, Anthony
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2009
Assuntos:
Cardiovascular and Metabolic Risk
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2646035/
https://ncbi.nlm.nih.gov/pubmed/18984774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-1543
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados